DK263689A - Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener - Google Patents
Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener Download PDFInfo
- Publication number
- DK263689A DK263689A DK263689A DK263689A DK263689A DK 263689 A DK263689 A DK 263689A DK 263689 A DK263689 A DK 263689A DK 263689 A DK263689 A DK 263689A DK 263689 A DK263689 A DK 263689A
- Authority
- DK
- Denmark
- Prior art keywords
- baculovirus
- expression vector
- modified
- procedure
- manufacturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8807207A FR2631974B1 (fr) | 1988-05-31 | 1988-05-31 | Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes |
Publications (2)
Publication Number | Publication Date |
---|---|
DK263689D0 DK263689D0 (da) | 1989-05-30 |
DK263689A true DK263689A (da) | 1989-12-01 |
Family
ID=9366759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK263689A DK263689A (da) | 1988-05-31 | 1989-05-30 | Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener |
Country Status (12)
Country | Link |
---|---|
US (1) | US5583023A (xx) |
EP (1) | EP0345152B1 (xx) |
JP (1) | JP3183877B2 (xx) |
AT (1) | ATE142257T1 (xx) |
AU (1) | AU626867B2 (xx) |
CA (1) | CA1341272C (xx) |
DE (1) | DE68927073T2 (xx) |
DK (1) | DK263689A (xx) |
FR (1) | FR2631974B1 (xx) |
NO (1) | NO892172L (xx) |
NZ (1) | NZ229369A (xx) |
PT (1) | PT90687B (xx) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5244805A (en) * | 1989-05-17 | 1993-09-14 | University Of Georgia Research Foundation, Inc. | Baculovirus expression vectors |
AU631223B2 (en) * | 1989-05-17 | 1992-11-19 | University Of Georgia Research Foundation, Inc., The | Improved baculovirus expression vectors |
GB9106185D0 (en) * | 1991-03-22 | 1991-05-08 | Wellcome Found | Biological control agents |
TW502065B (en) * | 1993-05-28 | 2002-09-11 | American Cyanamid Co | Gene insertion by direct ligation in vitro |
FR2724182B1 (fr) * | 1994-09-02 | 1996-12-13 | Pasteur Institut | Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations |
FR2724393A1 (fr) * | 1994-09-12 | 1996-03-15 | Inst Nat Sante Rech Med | Obtention d'un anticorps monoclonal recombinant humanise a partir d'un anticorps monoclonal murin, sa production en cellules d'insecte, et ses utilisations |
FR2732035B1 (fr) * | 1995-03-23 | 1997-05-30 | Agronomique Inst Nat Rech | Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede |
EP0983364B1 (en) | 1997-03-12 | 2002-06-12 | PE Corporation (NY) | Dna polymerases having improved labeled nucleotide incorporation properties |
US20050042629A1 (en) | 2002-09-13 | 2005-02-24 | Applera Corporation | Thermus scotoductus nucleic acid polymerases |
ZA200700168B (en) | 2001-10-10 | 2010-02-24 | Novo Nordisk As | Remodeling and glycoconjugation of peptides |
AU2004236174B2 (en) | 2001-10-10 | 2011-06-02 | Novo Nordisk A/S | Glycopegylation methods and proteins/peptides produced by the methods |
CN102180944A (zh) | 2001-10-10 | 2011-09-14 | 诺和诺德公司 | 肽的重构和糖缀合 |
AU2002346498A1 (en) | 2001-11-30 | 2003-06-17 | Applera Corporation | Thermus brockianus nucleic acid polymerases |
US8906676B2 (en) | 2004-02-02 | 2014-12-09 | Ambrx, Inc. | Modified human four helical bundle polypeptides and their uses |
KR101699142B1 (ko) | 2004-06-18 | 2017-01-23 | 암브룩스, 인코포레이티드 | 신규 항원-결합 폴리펩티드 및 이의 용도 |
JP2008507280A (ja) | 2004-07-21 | 2008-03-13 | アンブレツクス・インコーポレイテツド | 非天然コードアミノ酸を用いた生合成ポリペプチド |
CN103520735B (zh) | 2004-12-22 | 2015-11-25 | Ambrx公司 | 包含非天然编码的氨基酸的人生长激素配方 |
MX2007007591A (es) | 2004-12-22 | 2007-07-25 | Ambrx Inc | Metodos para expresion y purificacion de hormona de crecimiento humano recombinante. |
JP2008525473A (ja) | 2004-12-22 | 2008-07-17 | アンブレツクス・インコーポレイテツド | 修飾されたヒト成長ホルモン |
SG158148A1 (en) | 2004-12-22 | 2010-01-29 | Ambrx Inc | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
CA2590429C (en) | 2004-12-22 | 2014-10-07 | Ambrx, Inc. | Compositions of aminoacyl-trna synthetase and uses thereof |
JP2008541769A (ja) * | 2005-06-03 | 2008-11-27 | アンブレツクス・インコーポレイテツド | 改善されたヒトインターフェロン分子及びそれらの使用 |
CN102703446B (zh) | 2005-08-18 | 2014-05-28 | Ambrx公司 | tRNA组合物和其用途 |
PL1954710T3 (pl) * | 2005-11-08 | 2011-09-30 | Ambrx Inc | Przyspieszacze do modyfikacji aminokwasów niewystępujących w przyrodzie i polipeptydów zbudowanych z aminokwasów nie występujących w przyrodzie |
PT2339014E (pt) * | 2005-11-16 | 2015-10-13 | Ambrx Inc | Métodos e composições compreendendo aminoácidos não-naturais |
US7745158B2 (en) * | 2005-12-14 | 2010-06-29 | Kimberly-Clark Worldwide, Inc. | Detection of secreted aspartyl proteases from Candida species |
CA2882445A1 (en) * | 2005-12-14 | 2007-06-21 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
WO2008030613A2 (en) * | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Hybrid suppressor trna for vertebrate cells |
ES2465473T3 (es) * | 2006-09-08 | 2014-06-05 | Ambrx, Inc. | Transcripción de arnt supresor en células de vertebrado |
KR20090060294A (ko) | 2006-09-08 | 2009-06-11 | 암브룩스, 인코포레이티드 | 변형된 인간 혈장 폴리펩티드 또는 Fc 스캐폴드 및 그의 용도 |
CN104163864B (zh) | 2007-03-30 | 2017-08-01 | Ambrx公司 | 经修饰fgf‑21多肽和其用途 |
AU2008247815B2 (en) * | 2007-05-02 | 2012-09-06 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
JP5547083B2 (ja) * | 2007-11-20 | 2014-07-09 | アンブルックス,インコーポレイテッド | 修飾されたインスリンポリペプチドおよびそれらの使用 |
CN103694337B (zh) | 2008-02-08 | 2016-03-02 | Ambrx公司 | 经修饰瘦素多肽和其用途 |
UA118536C2 (uk) * | 2008-07-23 | 2019-02-11 | Амбркс, Інк. | Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування |
NZ607477A (en) | 2008-09-26 | 2014-09-26 | Ambrx Inc | Non-natural amino acid replication-dependent microorganisms and vaccines |
KR101647164B1 (ko) | 2008-09-26 | 2016-08-09 | 암브룩스, 인코포레이티드 | 변형된 동물 에리트로포이에틴 폴리펩티드 및 이의 용도 |
CN107674121A (zh) | 2009-12-21 | 2018-02-09 | Ambrx 公司 | 经过修饰的牛促生长素多肽和其用途 |
CN107056929A (zh) | 2009-12-21 | 2017-08-18 | Ambrx 公司 | 经过修饰的猪促生长素多肽和其用途 |
MX346786B (es) | 2010-08-17 | 2017-03-31 | Ambrx Inc | Polipeptidos de relaxina modificados y sus usos. |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
AR083006A1 (es) | 2010-09-23 | 2013-01-23 | Lilly Co Eli | Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas |
US20140017263A1 (en) | 2012-06-28 | 2014-01-16 | Clemson University | Delivery Agents for Targeted Treatment of Elastin Degradation |
EP2948552A4 (en) | 2013-01-28 | 2016-08-24 | Univ Kansas State | RIFTTALFIEBERVIRUS GLYCOPROTEINS GN AND GC AND THEIR USE |
PL3412302T3 (pl) | 2014-10-24 | 2021-11-02 | Bristol-Myers Squibb Company | Zmodyfikowane polipeptydy fgf-21 i ich zastosowania |
CN110637027B (zh) | 2017-02-08 | 2024-08-30 | 百时美施贵宝公司 | 包含药代动力学增强子的修饰的松弛素多肽及其用途 |
TWI744705B (zh) * | 2018-10-18 | 2021-11-01 | 中央研究院 | 偵測殺蟲劑的方法及套組、以及製備偵測殺蟲劑之方法及套組的質體、桿狀病毒、細胞及方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1202581A (en) * | 1980-03-27 | 1986-04-01 | Saran A. Narang | Adaptor molecules for dna and their application to synthesis of gene-derived products |
US4419446A (en) * | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
EP0074808A3 (en) * | 1981-09-16 | 1984-07-04 | University Patents, Inc. | Recombinant method and materials |
EP0127839B1 (en) * | 1983-05-27 | 1992-07-15 | THE TEXAS A&M UNIVERSITY SYSTEM | Method for producing a recombinant baculovirus expression vector |
FR2571737B1 (fr) * | 1984-10-15 | 1987-02-20 | Agronomique Inst Nat Rech | Vecteurs de clonage ou d'expression comportant le genome du virus de l'erythroblastose aviaire et cellules transfectees par ces vecteurs |
IE60285B1 (en) * | 1985-12-18 | 1994-06-29 | Microgenesys Inc | Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom |
EP0349594A4 (en) * | 1987-03-16 | 1990-09-26 | American Biogenetic Sciences, Inc. | Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
EP0364492A1 (en) * | 1987-06-30 | 1990-04-25 | The Upjohn Company | Virus proteins having reduced o-linked glycosylation |
WO1989001037A1 (en) * | 1987-07-24 | 1989-02-09 | Cetus Corporation | Production of ricin toxins in a baculovirus-insect cell expression system |
-
1988
- 1988-05-31 FR FR8807207A patent/FR2631974B1/fr not_active Expired - Lifetime
-
1989
- 1989-05-29 AU AU35291/89A patent/AU626867B2/en not_active Ceased
- 1989-05-29 CA CA000600958A patent/CA1341272C/fr not_active Expired - Fee Related
- 1989-05-30 NO NO89892172A patent/NO892172L/no unknown
- 1989-05-30 PT PT90687A patent/PT90687B/pt not_active IP Right Cessation
- 1989-05-30 DK DK263689A patent/DK263689A/da not_active Application Discontinuation
- 1989-05-31 EP EP89401483A patent/EP0345152B1/fr not_active Expired - Lifetime
- 1989-05-31 DE DE68927073T patent/DE68927073T2/de not_active Expired - Fee Related
- 1989-05-31 NZ NZ229369A patent/NZ229369A/xx unknown
- 1989-05-31 JP JP13898789A patent/JP3183877B2/ja not_active Expired - Fee Related
- 1989-05-31 AT AT89401483T patent/ATE142257T1/de not_active IP Right Cessation
-
1994
- 1994-12-14 US US08/355,824 patent/US5583023A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE68927073T2 (de) | 1997-03-27 |
JP3183877B2 (ja) | 2001-07-09 |
AU3529189A (en) | 1989-12-07 |
FR2631974A1 (fr) | 1989-12-01 |
CA1341272C (fr) | 2001-07-10 |
AU626867B2 (en) | 1992-08-13 |
US5583023A (en) | 1996-12-10 |
EP0345152B1 (fr) | 1996-09-04 |
JPH0235092A (ja) | 1990-02-05 |
DE68927073D1 (de) | 1996-10-10 |
PT90687B (pt) | 1994-10-31 |
EP0345152A1 (fr) | 1989-12-06 |
PT90687A (pt) | 1989-11-30 |
FR2631974B1 (fr) | 1992-12-11 |
DK263689D0 (da) | 1989-05-30 |
NZ229369A (en) | 1991-07-26 |
NO892172L (no) | 1989-12-01 |
NO892172D0 (no) | 1989-05-30 |
ATE142257T1 (de) | 1996-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK263689A (da) | Modificeret baculovirus, fremgangsmaade til dets fremstilling samt dets anvendelse som ekspressionsvektor for gener | |
LU91304I2 (fr) | A tryn-antithrombin alfa | |
ES532825A0 (es) | Un metodo de sintetizar un polipeptido seleccionado | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
NO179253C (no) | Rekombinant DNA-sekvens som koder for humant proapolipoprotein A-I, ekspresjonsvektorer, cellekulturer samt fremgangsmåte for fremstilling av proteinet | |
DK645887A (da) | Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse | |
FI944136A0 (fi) | Koostumuksia ja menetelmä sialyylitransferaasien identifioimiseksi ja syntesoimiseksi | |
DE69217144D1 (de) | Regulator-DNA zur Gen-Expression | |
PT83968B (pt) | Processo para melhoramento da expressao de proteina eucariotica, de preparacao de um plasmideo e plasmideo | |
NO177570B (no) | Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper | |
DK315582A (da) | T4 dna-fragment som stabilisator for proteiner udtrykt ved klonet dna | |
GB8615263D0 (en) | Light inducible promoter | |
ES2097368T3 (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres. | |
ATE116687T1 (de) | Stamm ral-4, nützlich zur herstellung kleiner proteine und peptide. | |
EA200100440A1 (ru) | Ген prv-1 и его применение | |
SE9101740D0 (sv) | Nya dna fragment och sekvenser | |
JPS6474988A (en) | Synthetic gene of cystatin c, corresponding recombinant plasmid and recombinant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |